Anti-Rickettsia conorii ompA Polyclonal Antibody from ProteoGenix; catalogue ARO-A22185; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Rickettsia Conorii ompA Polyclonal Antibody: A Powerful Tool for Detecting and Treating Rickettsial Infections
The Anti-Rickettsia Conorii ompA Polyclonal Antibody is a highly specific and sensitive antibody that has been designed to target the outer membrane protein A (ompA) of Rickettsia conorii, a bacterium known to cause rickettsial infections in humans. This antibody is a valuable tool for researchers and clinicians alike, offering a reliable and efficient means of detecting and treating these potentially life-threatening infections.
The Anti-Rickettsia Conorii ompA Polyclonal Antibody works by binding to the ompA protein on the surface of Rickettsia conorii. This protein is essential for the bacterium’s survival and is therefore highly conserved, making it an ideal target for detection and treatment. By binding to ompA, the antibody can effectively neutralize the bacterium and prevent it from causing harm to the host.
This antibody has a wide range of applications in both research and clinical settings. In research, it can be used for the detection and identification of Rickettsia conorii in various samples, such as blood, tissue, and body fluids. It is also a valuable tool for studying the pathogenesis and virulence of this bacterium.
In clinical settings, the Anti-Rickettsia Conorii ompA Polyclonal Antibody can be used for the diagnosis of rickettsial infections. It can accurately detect the presence of Rickettsia conorii in patient samples, allowing for early and effective treatment. Additionally, this antibody can be used for monitoring the effectiveness of treatment and for studying the development of antibiotic resistance in Rickettsia conorii.
The Anti-Rickettsia Conorii ompA Polyclonal Antibody has been successfully used in various experimental settings, including enzyme-linked immunosorbent assays (ELISA), immunofluorescence assays, and Western blotting. Its high specificity and sensitivity make it a reliable tool for these techniques, allowing for accurate and reproducible results.
In addition, this antibody has shown promising results in animal studies, where it has been used to treat rickettsial infections and prevent their spread. Its effectiveness in these studies highlights its potential as a therapeutic option for human patients.
Conclusion:
In summary, the Anti-Rickettsia Conorii ompA Polyclonal Antibody is a powerful tool for detecting and treating rickettsial infections. Its high specificity, sensitivity, and versatility make it a valuable asset for researchers and clinicians working in the field of biotechnology. With its ability to accurately detect and neutralize Rickettsia conorii, this antibody has the potential to save lives and improve the understanding of these complex infections. Order now and experience the benefits of this cutting-edge biotech product.
ProteoGenix catalogue number ARO-A22185. For research use only.
Target: Outer membrane protein A; 190 kDa antigen; Cell surface antigen; rOmp A; rOmpA; 120 kDa surface-exposed protein; 120 kDa outer membrane protein OmpA; 32 kDa beta peptide; ompA; RC1273; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Outer membrane protein A; 190 kDa antigen; Cell surface antigen; rOmp A; rOmpA; 120 kDa surface-exposed protein; 120 kDa outer membrane protein OmpA; 32 kDa beta peptide; ompA; RC1273 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
